| 12006500 |
Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) |
Danny Q. Tang, Xueping Chen, Patrick Y. Lu, David Michael Evans, John J. Xu +2 more |
2024-06-11 |
| 11697813 |
Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis |
John J. Xu, Patrick Y. Lu, Jia Zhou, Qingfeng Li |
2023-07-11 |
| 11058779 |
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection |
Patrick Y. Lu, Yibin Cai, John J. Xu, David Michael Evans |
2021-07-13 |
| RE46873 |
Multi-targeted RNAi therapeutics for scarless wound healing of skin |
Patrick Y. Lu, Ling Li |
2018-05-29 |
| 9642873 |
Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application |
Patrick Y. Lu, David Michael Evans, John J. Xu |
2017-05-09 |
| 8735567 |
Multi-targeted RNAi therapeutics for scarless wound healing of skin |
Patrick Y. Lu, Ling Li |
2014-05-27 |